Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
Nature1992Vol. 359(6396), pp. 641–644
Citations Over TimeTop 1% of 1992 papers
François Cambien, Odette Poirier, Laure Lecerf, Alun Evans, Jean‐Pierre Cambou, Dominique Arveiler, Gérald Luc, Jean‐Marie Bard, L. Bara, Sylvain Ricard, Laurence Tiret, Philippe Amouyel, François Alhenc‐Gelas, Florent Soubrier
Related Papers
- → Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors(1998)17 cited
- → ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS AND KININ METABOLISM: EVIDENCE THAT ACE INHIBITORS MAY INHIBIT A KININASE OTHER THAN ACE(1995)33 cited
- → Involvement of the kallikrein‐kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.(1989)12 cited
- → ROLE OF ANGIOTENSIN III IN THE REGULATION OF BLOOD PRESSURE, PLASMA ALDOSTERONE AND PLASMA RENIN ACTIVITY IN RABBIT(1978)8 cited
- Bradykinin analogs as inhibitors of angiotensin-converting enzyme.(1994)